Similar articles for PMID: 25655342

Year	Number of Results
1960	1
2000	1
2003	1
2004	3
2005	9
2006	8
2007	12
2008	11
2009	9
2010	7
2011	13
2012	14
2013	23
2014	42
2015	46
2016	17
2017	6
2018	8
2019	2
2020	4
2021	3
2022	5
2023	3
2024	0

1

18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.

Surasi DS, O'Malley JP, Bhambhvani P. Surasi DS, et al. J Nucl Med Technol. 2015 Sep;43(3):229-30. doi: 10.2967/jnmt.114.152777. Epub 2015 Feb 5. J Nucl Med Technol. 2015. PMID: 25655342 Free article. Review.

2

The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.

Hu S, Zhang J, Cheng C, Liu Q, Sun G, Zuo C. Hu S, et al. Abdom Imaging. 2014 Dec;39(6):1221-7. doi: 10.1007/s00261-014-0170-5. Abdom Imaging. 2014. PMID: 24913670

3

The impact of 18F-FDG PET/CT in patients with liver metastases.

Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y, Bomanji JB, Ell PJ. Chua SC, et al. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):1906-14. doi: 10.1007/s00259-007-0518-y. Epub 2007 Aug 23. Eur J Nucl Med Mol Imaging. 2007. PMID: 17713766

4

Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?

Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV. Parvizi N, et al. Eur J Radiol. 2015 Oct;84(10):1873-8. doi: 10.1016/j.ejrad.2015.06.025. Epub 2015 Jun 29. Eur J Radiol. 2015. PMID: 26163992

5

Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.

Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wei JH, Wu H. Sun L, et al. World J Gastroenterol. 2008 Feb 28;14(8):1212-7. doi: 10.3748/wjg.14.1212. World J Gastroenterol. 2008. PMID: 18300346 Free PMC article.

6

Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.

Armbruster M, Zech CJ, Sourbron S, Ceelen F, Auernhammer CJ, Rist C, Haug A, Singnurkar A, Reiser MF, Sommer WH. Armbruster M, et al. J Magn Reson Imaging. 2014 Aug;40(2):457-66. doi: 10.1002/jmri.24363. Epub 2013 Dec 18. J Magn Reson Imaging. 2014. PMID: 24347148

7

Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.

Armbruster M, Sourbron S, Haug A, Zech CJ, Ingrisch M, Auernhammer CJ, Nikolaou K, Paprottka PM, Rist C, Reiser MF, Sommer WH. Armbruster M, et al. Invest Radiol. 2014 Jan;49(1):7-14. doi: 10.1097/RLI.0b013e3182a4eb4a. Invest Radiol. 2014. PMID: 24002080

8

The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.

Zhang X, Wu F, Han P. Zhang X, et al. Hell J Nucl Med. 2014 Sep-Dec;17(3):177-83. Hell J Nucl Med. 2014. PMID: 25526754

9

[Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].

Fuster D, Lafuente S, Setoain X, Navales I, Perissinotti A, Pavia J, Paredes P, Lomeña F, Pons F. Fuster D, et al. Rev Esp Med Nucl Imagen Mol. 2012 May-Jun;31(3):111-6. doi: 10.1016/j.remn.2011.10.006. Epub 2011 Dec 7. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 22154291 Clinical Trial. Spanish.

10

Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.

Ng SP, David S, Alamgeer M, Ganju V. Ng SP, et al. Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):111-7. doi: 10.1016/j.ijrobp.2015.05.012. Epub 2015 May 15. Int J Radiat Oncol Biol Phys. 2015. PMID: 26279029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

221 results

Results by year